Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Bunge Global
BG
$20.8B
| $37.6M | 0.01% |
462,525
+76,713
| +20% | +$6.15M |
|
902
PUT
EQT Corp
EQT
$32.3B
| $37.6M | 0.01% |
690,400
-1,391,900
| -67% | -$73.5M |
|
903
Plains All American Pipeline
PAA
$16.1B
| $37.6M | 0.01% |
2,201,285
+59,392
| +3% | +$1.06M |
|
904
CALL
3M
MMM
$94.3B
| $37.4M | 0.01% |
+241,300
| New | +$37.2M |
|
905
Hims & Hers Health
HIMS
$7.31B
| $37.4M | 0.01% |
658,971
+44,292
| +7% | +$2.27M |
|
906
BridgeBio Pharma
BBIO
$16.5B
| $37.4M | 0.01% |
719,448
-214,064
| -23% | -$10.4M |
|
907
PUT
Johnson & Johnson
JNJ
$625B
| $37.2M | 0.01% |
200,600
+20,800
| +12% | +$3.56M |
|
908
CALL
Las Vegas Sands
LVS
$29.6B
| $36.9M | 0.01% |
686,000
+300,500
| +78% | +$15.8M |
|
909
AGCO
AGCO
$7.2B
| $36.8M | 0.01% |
343,546
-55,981
| -14% | -$6.18M |
|
910
PUT
Cigna
CI
$74.6B
| $36.8M | 0.01% |
+127,500
| New | +$37.7M |
|
911
Avery Dennison
AVY
$13.4B
| $36.7M | 0.01% |
226,583
-49,773
| -18% | -$8.58M |
|
912
West Pharmaceutical
WST
$24.9B
| $36.7M | 0.01% |
140,016
-59,572
| -30% | -$14.5M |
|
913
Jacobs Solutions
J
$17B
| $36.7M | 0.01% |
244,792
-97,254
| -28% | -$14M |
|
914
Alaska Air
ALK
$5.58B
| $36.7M | 0.01% |
736,356
-206,965
| -22% | -$11.5M |
|
915
Coca-Cola Consolidated
COKE
$12.8B
| $36.6M | 0.01% |
312,212
-37,715
| -11% | -$4.37M |
|
|
NBIS
916
CALL
Nebius Group N.V.
NBIS
$47.7B
| $36.6M | 0.01% |
325,800
+230,800
| +243% | +$16M |
|
917
Upstart Holdings
UPST
$3.03B
| $36.5M | 0.01% |
719,410
+135,539
| +23% | +$9.54M |
|
918
Markel Group
MKL
$23.2B
| $36.5M | 0.01% |
19,091
+309
| +2% | +$606K |
|
919
Darling Ingredients
DAR
$9.44B
| $36.3M | 0.01% |
1,176,293
+609,145
| +107% | +$20.3M |
|
920
PUT
Super Micro Computer
SMCI
$20.1B
| $36.3M | 0.01% |
757,300
+732,300
| +2,929% | +$35M |
|
921
PUT
Westlake Corp
WLK
$9.89B
| $36.3M | 0.01% |
+470,500
| New | +$39.2M |
|
|
FLG
922
Flagstar Bank National Association
FLG
$5.82B
| $36M | 0.01% |
3,118,855
+1,690,435
| +118% | +$20.1M |
|
923
PUT
Darden Restaurants
DRI
$24.4B
| $35.9M | 0.01% |
+188,700
| New | +$38.8M |
|
924
Semtech
SMTC
$13B
| $35.9M | 0.01% |
502,162
+329,390
| +191% | +$17.9M |
|
925
Graco
GGG
$13.5B
| $35.5M | 0.01% |
417,353
+219,248
| +111% | +$18.8M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.